FibroBiologics, Inc.

US$0.98As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FBLGHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (90.03%)
Div yield —
ROE (660.08%)
Biotechnology
Beta (5Y) 1.84
PE TTM —
TSR TTM (87.55%)
Mkt cap US$6.815M
ROIC (117.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.20
22.69%
525.56%
Hold 12|12|1|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.03
0.03
2.38%
16.60%
29.21%
16.07%
Revenue$M
0.725
0.766
0.746
0.734
0.93%
7.66%
6.46%
3.43%
Peers (US$6.815M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.399
0.546
0.388
EBIT/Intx
2.014
0.914
0.855
Own earn%
(9.22)
(38.62)
(49.70)
Sh yield%
27.54
28.76
29.95
Owners
Insiders/Inst%
9.51
32.85
Short interest%
3.87
SBC / revenue%
4.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
0–9
$1 testx
0.0
Incr. ROIC%
0